"Action at a distance" may be the new norm for clinical researchers in the context of the COVID-19 pandemic, which may require social distancing for the next 18 months. We must minimize face-to-face contact with vulnerable populations.
Statins are a therapeutic drug with reducing plasma cholesterol levels and have been linked with potential antitumor effects. However, epidemiological studies on statin use and renal cell carcinoma (RCC) risk have been inconsistent.
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
